Postacute coronavirus disease 2019 acute ischemic stroke profile and outcome among egyptians

Author:

Gado Ismaeil H.A.1,Elkourdy Alaa M.E.1,khalfallah Mohamed A.2,El-Heneedy Yasser A.-F.H.1

Affiliation:

1. Department of Neuropsychiatry, Tanta University, Tanta, Egypt

2. Department of Cardiology, Faculty of Medicine, Tanta University, Tanta, Egypt

Abstract

Background Coronavirus disease 2019 (COVID-19) is the most dangerous global health crisis since the era of the influenza pandemic 1918. Aim The aim of this work was to study the characteristics and short-term outcomes of acute ischemic stroke (AIS) in patients recovered from COVID-19 among a sample of the Egyptian population. Patients and methods The cross-sectional prospective study included 108 patients: 58 patients with AIS documented by brain cranial computed tomography and/or brain magnetic resonance imaging (MRI) who recovered from COVID-19 infection for at least 3 months and another 50 patients (control) without history of COVID-19 infection. Neurological examination including Glasgow Coma Score, National Institute of Health Stroke Scale (NIHSS) and Oxfordshire Community Stroke Project Classification classification as well as TOAST classification done for all patients. Results Regarding modified ranking scale (MRS), a mild increase in the patient group is detected but without significant difference between both groups. Regarding mortality, it was significantly higher in the patient group than in the control group. The relation between presenting symptoms of COVID-19, severity of previous COVID-19, and type of previous infection with NIHSS and MRS of patients, revealed that respiratory manifestations associated with higher NIHSS and MRS. Relation between lymphopenia, erythrocyte sedimentation rate, NIHSS, and MRS revealed inverse relationship between lymphocytic count and NIHSS and MRS, while positive relationship was detected between erythrocyte sedimentation rate, NIHSS, and MRS. Conclusion Postacute COVID-19 AIS has characteristic features regarding risk factors, clinical presentation, investigations, etiology, and outcome. The risk of AIS must be considered when the patient has beedn previously infected with COVID-19.

Publisher

Medknow

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3